COI.
search Request for Consideration arrow_forward menu
close Submit Innovation
close
Biotechnology verified Verified Outcome TRL 9

Population-Scale Genomic Sequencing

domain Client: A global leader in biotechnology handshake Provider: AWS / Databricks schedule Deploy: 2023
85 Impact
Enterprise Ready
Evidence Score: A/10
Strength: High

Executive Summary

ANALYST: COI RESEARCH

Architecture of a cloud-native genomics pipeline to ingest and analyze exome sequences from over 500,000 UK Biobank participants.

rate_review Analyst Verdict

"Low Risk. Validates the hyperscaler model for genomics; on-premise storage of petabyte-scale sequencing data is no longer economically viable."

lock
Full Audit Report Available Includes Risk Register, Technical Specs & Compliance Data.

warning The Challenge

Ingesting and processing 2 petabytes of genomic data for 500,000 individuals created an infrastructure bottleneck. Legacy on-premise compute could not burst to handle the irregular, massive workloads required for variant calling.

psychology The Solution

Built a serverless data pipeline on AWS. Utilized Amazon EC2 Spot Instances to reduce compute costs for heavy batch processing and S3 for tiered storage of raw genomic files.

settings_suggest Technical & Deployment Specs

Integrations
LIMS / Sequencing Instruments
Deployment Model
IaaS
Data Classification
Genomic / De-identified
Estimated TCO / ROI
High (Storage)
POC Summary ( to )

"N/A"

shield Risk Register & Mitigation

Risk Factor Severity Mitigation Strategy
Data Egress Costs Medium Compute-in-place architecture

trending_up Impact Trajectory

Audited value realization curve

Processed >500,000 exomes Verified Outcome
Primary KPIReduced query time from days to minutes
Audit CycleIdentified new gene targets for obesity and liver disease

policy Compliance & Gov

  • Standards: HIPAA / GxP
  • Maturity (TRL): 9
  • Evidence Score: A/10
  • Data Class: Genomic / De-identified

folder_shared Verified Assets

description
Verified Case Study
PDF • Version 1
lock
verified_user
Technical Audit
PDF • Audited
lock

Related Intelligence

article
Biometric Identity for Venue Entry
View Outcome →
article
Cloud ERP & Financial Reporting Migration
View Outcome →
article
Financial Data Platform as a Service
View Outcome →
Security Architecture

The "Blind Verification" Protocol

How we verified these outcomes for A global leader in biotechnology without exposing sensitive IP or identities.

Private
lock_person

1. Raw Evidence

Audit ID: #PRIV-502
Evidence: Direct SQL Logs
Public
public

2. Verified Asset

Outcome: Verified
Ref ID: #COI-502

Strategic Action Center

Identify your current stage and take the next step.

rocket_launch
Replicate This Success
Want similar results? Request a deployment consultation.
psychology_alt
Submit Challenge
Have a different problem? Submit your problem statement.
publish
Publish Case Study
Submit your own verified evidence.
thumb_up
Verify Impact
Audit your existing solution.